| Literature DB >> 20470803 |
Sok Touch1, Chutima Suraratdecha, Chham Samnang, Seng Heng, Lauren Gazley, Chea Huch, Ly Sovann, Chab Seak Chhay, Sann Chan Soeung.
Abstract
This study aimed to evaluate the cost and effectiveness of introducing a live, attenuated vaccine (SA 14-14-2) against Japanese encephalitis (JE) into the immunization program. The study demonstrated that SA 14-14-2 immunization is cost-effective in controlling JE in Cambodia compared to no vaccination. Averting one disability-adjusted life year, from a societal perspective, through the introduction of SA 14-14-2 through routine immunization, or a combination of routine immunization plus a campaign targeting children 1-5 or 1-10 years of age, costs US$22, US$34 and US$53, respectively. Sensitivity analyses confirmed that there was a high probability of SA 14-14-2 immunization being cost-effective under conditions of uncertainty. (c) 2010 Elsevier Ltd. All rights reserved.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20470803 DOI： 10.1016/j.vaccine.2010.04.086
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641